The Venture Codex Logo

The Venture Codex

Shionogi & Co.

1-8, Doshomachi 3-chome, Chuo-ku, Osaka, 541-0045, Japan

Overview

Pharmaceuticals and medical devices with a focus on generics.

Founded

1878

Deals ยท 12mo

3

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series D

Geographic focus

Japan
United States

Sector focus

Biotechnology
Medical Device
Pharmaceutical
Product Research

Investment portfolio

4rounds
NAMEDATESIZE
Celaid Therapeutics
Oct 2026Led
$3 MSeries B
Dioseve
Jun 2026Participated
$6 MSeries A
Restore Vision
Apr 2026Participated
$8 MSeries B
Akili Interactive Labs
May 2021Participated
$160 MSeries D
Celaid Therapeutics
Oct 2026Led
$3 MSeries B
Dioseve
Jun 2026Participated
$6 MSeries A
Restore Vision
Apr 2026Participated
$8 MSeries B
Akili Interactive Labs
May 2021Participated
$160 MSeries D
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Shionogi & Co.: 4 funding rounds are recorded in the selected participation categories.All available history.
Shionogi & Co.: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B11
Series C+01

Monthly Deal Activity

Shionogi & Co.: 4 deals are recorded across 66 months.All available history.
Shionogi & Co.: 4 deals are recorded across 66 months. All available history
MonthDeals
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '261
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

Shionogi & Co.: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Shionogi & Co.: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Networks, Cloud & Communication1
Manufacturing1
Space & Frontier Tech1

Deal Size Distribution

Shionogi & Co.: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Shionogi & Co.: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M2
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Shionogi & Co.: Japan has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Shionogi & Co.: Japan has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Japan3
United States1
Shionogi & Co.: 20 co-investors are shown, with Ajinomoto sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Shionogi & Co.: 20 co-investors are shown, with Ajinomoto sharing 1 recorded deals. All available history
Co-investorShared deals
Ajinomoto1
Amgen Ventures1
Archetype Ventures1
Astellas Venture Management1
Baillie Gifford1
Canepa Advanced Healthcare Fund1
D4V1
DG Daiwa Ventures1
Fearless Ventures1
Japan Science and Technology Agency1
Japan Venture Capital1
JAZZ Venture Partners1
JIC Venture Growth Investments1
Kyoto University Innovation Capital1
Ladera Venture Partners1
M Ventures1
Mirae Asset1
Miraidoa (Future Venture Capital)1
Neuberger Berman1
New Leaf Venture Partners1

Investment Strategy

Shionogi & Co.: Led accounts for 25% and participating for 75% of round participation.All available history.
Shionogi & Co.: Led accounts for 25% and participating for 75% of round participation. All available history
CategoryDeals (count)Share (%)
Led125%
Participating375%
Shionogi & Co.: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Shionogi & Co.: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Ed Schutter

President and Chief Operating Officer

Jimmy Chen

Senior Director, Pharmaceutical Sciences

KEISUKE KUSUMOTO

Director/Head of Corporate Venture Capital/Corporate Planning Dep

Lance Bennett

KAM Leader, West Region

Margaret Borys

SVP & Chief Commercial Officer

Ramon Polo

Senior Vice President, Head of Global Regulatory Affairs

Suzie Henderson

Senior Submission Manager, Regulatory Affairs